Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

被引:80
作者
Gao, Shuai [1 ,2 ,3 ,4 ]
Gao, Yanfei [2 ,3 ,4 ,5 ]
He, Housheng Hansen [6 ]
Han, Dong [1 ]
Han, Wanting [1 ]
Avery, Amy [1 ]
Macoska, Jill A. [1 ]
Liu, Xiaming [7 ]
Chen, Sen [2 ,3 ,4 ]
Ma, Fen [2 ,3 ,4 ]
Chen, Shaoyong [2 ,3 ,4 ]
Balk, Steven P. [2 ,3 ,4 ]
Cai, Changmeng [1 ,2 ,3 ,4 ]
机构
[1] Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA
[2] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA
[4] Harvard Med Sch, Boston, MA 02215 USA
[5] Chongqing Med Univ, Affiliated Hosp 2, Dept Orthoped, Chongqing 400010, Peoples R China
[6] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada
[7] Tongji Hosp, Dept Urol, Wuhan 430030, Hubei, Peoples R China
关键词
PROSTATE-CANCER; INCREASED SURVIVAL; EXPRESSION; MECHANISMS; BETA; PROGRESSION; METABOLISM; RESISTANCE; THERAPY; TARGET;
D O I
10.1016/j.celrep.2016.09.064
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although well characterized as a transcriptional activator that drives prostate cancer (PCa) growth, androgen receptor (AR) can function as a transcriptional repressor, and high-level androgens can suppress PCa proliferation. The molecular basis for this repression activity remains to be determined. Genes required for DNA replication are highly enriched among androgen-repressed genes, and AR is recruited to the majority of these genes, where it rapidly represses their transcription. This activity is enhanced in PCa cells expressing high AR levels and is mediated by recruitment of hypophosphorylated retinoblastoma protein (Rb). Significantly, AR also indirectly increases the expression of DNA replication genes through stimulatory effects on other metabolic genes with subsequent CDK activation and Rb hyperphosphorylation. In castration-resistant PCa cells, which are dependent on high-level AR expression, this anti-proliferative repression function might be exploited through treatment with androgen in combination with agents that suppress AR-driven metabolic functions or cell cycle progression.
引用
收藏
页码:966 / 976
页数:11
相关论文
共 28 条
[1]   Androgens Suppress EZH2 Expression Via Retinoblastoma (RB) and p130-Dependent Pathways: A Potential Mechanism of Androgen-Refractory Progression of Prostate Cancer [J].
Bohrer, Laura R. ;
Chen, Shuai ;
Hallstrom, Timothy C. ;
Huang, Haojie .
ENDOCRINOLOGY, 2010, 151 (11) :5136-5145
[2]   Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1 [J].
Cai, Changmeng ;
He, Housheng Hansen ;
Chen, Sen ;
Coleman, Ilsa ;
Wang, Hongyun ;
Fang, Zi ;
Chen, Shaoyong ;
Nelson, Peter S. ;
Liu, X. Shirley ;
Brown, Myles ;
Balk, Steven P. .
CANCER CELL, 2011, 20 (04) :457-471
[3]   Molecular determinants of resistance to antiandrogen therapy [J].
Chen, CD ;
Welsbie, DS ;
Tran, C ;
Baek, SH ;
Chen, R ;
Vessella, R ;
Rosenfeld, MG ;
Sawyers, CL .
NATURE MEDICINE, 2004, 10 (01) :33-39
[4]   Androgen suppression of GnRH-stimulated rat LHβ gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region [J].
Curtin, D ;
Jenkins, S ;
Farmer, N ;
Anderson, AC ;
Haisenleder, DJ ;
Rissman, E ;
Wilson, EM ;
Shupnik, MA .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (11) :1906-1917
[5]   Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].
De Bono, Johann S. ;
Logothetis, Christopher J. ;
Molina, Arturo ;
Fizazi, Karim ;
North, Scott ;
Chu, Luis ;
Chi, Kim N. ;
Jones, Robert J. ;
Goodman, Oscar B., Jr. ;
Saad, Fred ;
Staffurth, John N. ;
Mainwaring, Paul ;
Harland, Stephen ;
Flaig, Thomas W. ;
Hutson, Thomas E. ;
Cheng, Tina ;
Patterson, Helen ;
Hainsworth, John D. ;
Ryan, Charles J. ;
Sternberg, Cora N. ;
Ellard, Susan L. ;
Flechon, Aude ;
Saleh, Mansoor ;
Scholz, Mark ;
Efstathiou, Eleni ;
Zivi, Andrea ;
Bianchini, Diletta ;
Loriot, Yohann ;
Chieffo, Nicole ;
Thian Kheoh ;
Haqq, Christopher M. ;
Scher, Howard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005
[6]   Molecular mechanisms underlying RB protein function [J].
Dick, Frederick A. ;
Rubin, Seth M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (05) :297-306
[7]   The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study [J].
Finn, Richard S. ;
Crown, John P. ;
Lang, Istvan ;
Boer, Katalin ;
Bondarenko, Igor M. ;
Kulyk, Sergey O. ;
Ettl, Johannes ;
Patel, Ravindranath ;
Pinter, Tamas ;
Schmidt, Marcus ;
Shparyk, Yaroslav ;
Thummala, Anu R. ;
Voytko, Nataliya L. ;
Fowst, Camilla ;
Huang, Xin ;
Kim, Sindy T. ;
Randolph, Sophia ;
Slamon, Dennis J. .
LANCET ONCOLOGY, 2015, 16 (01) :25-35
[8]   Androgen action and metabolism in prostate cancer [J].
Green, Sean M. ;
Mostaghel, Elahe A. ;
Nelson, Peter S. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) :3-13
[9]  
Gregory CW, 2001, CANCER RES, V61, P2892
[10]   Androgen receptor-mediated gene repression [J].
Grosse, Andreas ;
Bartsch, Sophie ;
Baniahmad, Aria .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 352 (1-2) :46-56